Reply to "Proper tumor classification and growth rate are key elements when considering indications and results of radiotherapy for head and neck paragangliomas"
Head Neck
.
2019 Aug;41(8):2837-2838.
doi: 10.1002/hed.25800.
Epub 2019 May 6.
Authors
Yasmin Lassen-Ramshad
1
2
,
Enis Ozyar
3
,
Senem Alanyali
4
,
Philip Poortmans
5
,
Paul Van Houtte
6
,
Schoeb Sohawon
6
,
Mustafa Esassolak
4
,
Marco Krengli
7
,
Salvador Villa
8
,
Robert C Miller
9
,
Candan Demiroz
10
,
Serap Akyurek
11
,
Ninna Aggerholm-Pedersen
2
,
Juliette Thariat
12
Affiliations
1
Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.
2
Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
3
Acibadem M.A. Aydinlar University, School of Medicine, Department of Radiation Oncology, Turkey.
4
Department of Radiation Oncology, Faculty of Medicine, Ege University, Turkey.
5
Department of Radiation Oncology, Institut Curie, Paris, France.
6
Department of Radiation Oncology, Jules Bordet Institute, Brussels, Belgium.
7
Department of Radiotherapy, University of Piemonte Orientale, Novara, Italy.
8
Department of Radiation Oncology, Catalan Institute of Oncology, Badalona, Spain.
9
Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida.
10
Uludag University Faculty of Medicine, Radiation Oncology Clinical Division, Turkey.
11
Department of Radiotherapy, Ankara University School of Medicine, Ankara, Turkey.
12
Radiation Oncology Department, Centre Francois Baclesse, Caen, France.
PMID:
31058391
DOI:
10.1002/hed.25800
No abstract available
Publication types
Letter
Comment
MeSH terms
Head and Neck Neoplasms*
Humans
Paraganglioma*
Paraganglioma, Extra-Adrenal*